• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减少血液透析患者的住院率:是时候进行范式转变了。

Decreasing hospitalizations in patients on hemodialysis: Time for a paradigm shift.

作者信息

Golestaneh Ladan

机构信息

Nephrology Division, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Semin Dial. 2018 May;31(3):278-288. doi: 10.1111/sdi.12675. Epub 2018 Feb 6.

DOI:10.1111/sdi.12675
PMID:29409160
Abstract

Hospitalizations drive up to 35% of the astronomical costs of care for patients on hemodialysis and are associated with poor outcomes. We describe outpatient care-sensitive categories of hospitalization risks in an effort to engage stakeholders and patients, as stakeholders, in mitigating hospitalizations. These categories include: (1) fluid (interdialytic weight gain (IDWG) and chronic volume status), (2) infection (vascular access and malnutrition/inflammation resilience), and c) psychosocial (poor social support, poor self-efficacy, and mood disorders) risks. Barriers to improving hospitalization outcomes, especially as they relate to above risk categories, exist at multiple stakeholder levels and include: (1) dialysis facilities (strict shift changes, personnel challenges), (2) nephrologists (static dialysis prescriptions and protocols based on dialysis facility metrics), and (3) patients (lack of engagement and self-efficacy). System-level elements, such as payment models, help to propagate these barriers. In this article, we seek to shift the care paradigm discussion to patient trajectories and long-term outcomes, and to active engagement of patients as self-managers, through which we hope to impact on high inpatient resource utilization. We will also focus attention on the complex interplay of practices that have become acceptable care structures, but that may be deleterious to outcomes. Only after thorough consideration of these topics can we hope to impact on this important problem.

摘要

住院治疗导致血液透析患者的护理费用高达天文数字的35%,且与不良预后相关。我们描述了门诊护理敏感型住院风险类别,以便让利益相关者和患者作为利益相关者参与到减少住院治疗中来。这些类别包括:(1)液体(透析间期体重增加(IDWG)和慢性容量状态)、(2)感染(血管通路和营养不良/炎症恢复力)以及(3)心理社会(社会支持不足、自我效能差和情绪障碍)风险。改善住院治疗结果存在障碍,尤其是与上述风险类别相关的障碍,这些障碍存在于多个利益相关者层面,包括:(1)透析设施(严格的轮班制度、人员挑战)、(2)肾病学家(基于透析设施指标的固定透析处方和方案)以及(3)患者(缺乏参与度和自我效能)。支付模式等系统层面的因素助长了这些障碍。在本文中,我们试图将护理模式的讨论转向患者轨迹和长期结果,并让患者积极参与自我管理,我们希望借此影响高住院资源利用率。我们还将关注那些已成为可接受的护理结构,但可能对结果有害的实践之间的复杂相互作用。只有在对这些主题进行充分考虑之后,我们才有希望影响这个重要问题。

相似文献

1
Decreasing hospitalizations in patients on hemodialysis: Time for a paradigm shift.减少血液透析患者的住院率:是时候进行范式转变了。
Semin Dial. 2018 May;31(3):278-288. doi: 10.1111/sdi.12675. Epub 2018 Feb 6.
2
Systemic barriers to vascular access care: implications for clinical outcomes.血管通路护理的系统性障碍:对临床结局的影响
Contrib Nephrol. 2004;142:350-62. doi: 10.1159/000074851.
3
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).透析间期体重增加:国际透析结局和实践模式研究(DOPPS)中的趋势、预测因素和相关结局。
Am J Kidney Dis. 2017 Mar;69(3):367-379. doi: 10.1053/j.ajkd.2016.08.030. Epub 2016 Nov 17.
4
Adherence to treatment and hospitalization risk in hemodialysis patients.血液透析患者的治疗依从性与住院风险。
J Nephrol. 2012 Sep-Oct;25(5):672-8. doi: 10.5301/jn.5000038.
5
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study.血液透析护理中临床绩效目标的达成、临床结局的改善及资源利用情况:一项前瞻性队列研究。
BMC Health Serv Res. 2007 Jan 9;7:5. doi: 10.1186/1472-6963-7-5.
6
Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients.血液透析患者血管通路及非血管通路相关住院的影响因素
Am J Nephrol. 1996;16(2):118-23. doi: 10.1159/000168982.
7
Public health surveillance in the dialysis setting: opportunities and challenges for using electronic health records.透析环境中的公共卫生监测:利用电子健康记录的机遇与挑战
Semin Dial. 2013 Jul-Aug;26(4):399-406. doi: 10.1111/sdi.12098. Epub 2013 May 31.
8
Hospital resource utilization that occurs with, rather than because of, kidney failure in patients with end-stage renal disease.终末期肾病患者因肾衰竭以外的原因而导致的医院资源利用情况。
Clin J Am Soc Nephrol. 2006 Nov;1(6):1234-40. doi: 10.2215/CJN.01210406. Epub 2006 Sep 6.
9
[Infection-related hospitalization of hemodialysis patients].[血液透析患者的感染相关住院治疗]
Medicina (Kaunas). 2007;43 Suppl 1:65-71.
10
Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.透析优化健康计划(DOHP)随机对照试验的设计与方案
Trials. 2016 Sep 9;17(1):447. doi: 10.1186/s13063-016-1558-z.

引用本文的文献

1
Risk Factors for Mortality Among Patients on Hemodialysis in India: A Case-Control Study.印度血液透析患者死亡的危险因素:一项病例对照研究。
Indian J Nephrol. 2025 May-Jun;35(3):390-396. doi: 10.25259/ijn_563_23. Epub 2024 Aug 8.
2
Feasibility of a Peer Mentor Training Program for Patients Receiving Hemodialysis: An Educational Program Evaluation.针对接受血液透析患者的同伴导师培训项目的可行性:一项教育项目评估
Kidney Med. 2023 Mar 20;5(5):100630. doi: 10.1016/j.xkme.2023.100630. eCollection 2023 May.
3
Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program.
医疗保健中按绩效付费计划的有效性:以终末期肾病质量激励计划为例。
Eur J Health Econ. 2024 Mar;25(2):221-236. doi: 10.1007/s10198-023-01582-x. Epub 2023 Mar 26.
4
Association of the nutritional risk index for Japanese hemodialysis with mortality and dietary nutritional intake in patients undergoing hemodialysis during long-term hospitalization.日本血液透析患者营养风险指数与长期住院血液透析患者死亡率及饮食营养摄入的相关性
Clin Exp Nephrol. 2022 Dec;26(12):1200-1207. doi: 10.1007/s10157-022-02259-0. Epub 2022 Aug 30.
5
Peer mentorship to improve outcomes in patients on hemodialysis (PEER-HD): a randomized controlled trial protocol.同伴指导改善血液透析患者结局(PEER-HD):一项随机对照试验方案。
BMC Nephrol. 2022 Mar 5;23(1):92. doi: 10.1186/s12882-022-02701-1.
6
Epidemiology of haemodialysis outcomes.血液透析结局的流行病学。
Nat Rev Nephrol. 2022 Jun;18(6):378-395. doi: 10.1038/s41581-022-00542-7. Epub 2022 Feb 22.
7
Challenges and novel therapies for vascular access in haemodialysis.血液透析血管通路的挑战和新疗法。
Nat Rev Nephrol. 2020 Oct;16(10):586-602. doi: 10.1038/s41581-020-0333-2. Epub 2020 Aug 24.